PRONTO-EYE rideshare program to help people with diabetic retinopathy get to eye appointments
Official title: Using Implementation Science to Adapt a Targeted Transportation Intervention for Patients With Diabetic Retinopathy (PRONTO-EYE)
Run by University of Illinois Chicago · NCT07296952 · Data updated 2026-11-12
This project tests whether a rideshare transportation program (PRONTO‑EYE) helps people with diabetic retinopathy who have Medicaid get to ophthalmology appointments more often.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 60 (estimated) |
| Sponsor | University of Illinois Chicago Academic / other |
| Locations | 1 site (Chicago, Illinois) |
| Status | Recruiting |
| Started | February 3, 2026 |
| Main results expected | June 30, 2026 |
| Study ends | June 1, 2027 |
| Registry record updated | February 27, 2026 |
| Trial ID | NCT07296952 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are established patients with a history of diabetic retinopathy who have Medicaid insurance, live within 25 miles of the clinic, and speak English.
✕Probably not a fit
Patients without Medicaid, those living farther than 25 miles from the clinic, non‑English speakers, or people who already have reliable transportation are unlikely to benefit from this intervention.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This is a type 3 hybrid effectiveness‑implementation pilot using human‑centered design to adapt and pilot a rideshare transportation intervention for patients with diabetic retinopathy and Medicaid. Investigators co‑designed PRONTO‑EYE through interviews, workshops, journey mapping, and prototyping, then implemented the program at a single clinical site. The primary focus is whether providing rideshare transport improves adherence to ophthalmology visits, while also gathering implementation outcomes. Participants are established clinic patients who have Medicaid insurance, a history of diabetic retinopathy, live within 25 miles of the clinic, and speak English.
Why it matters
Potential benefit: If successful, the program could increase appointment attendance and reduce delays in DR care by removing transportation barriers for Medicaid patients.
How similar studies have gone: Rideshare and transportation programs have improved appointment attendance in other healthcare settings, but applying a co‑designed rideshare intervention specifically for Medicaid patients with diabetic retinopathy is relatively novel.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Established patient * Medicaid insurance * History of diabetic retinopathy * Lives within 25 miles of the clinic * English speaking
Where it's running
-
UI Health
Chicago, Illinois, United States Recruiting
Study contacts
- Study coordinator: Angelica Scanzera, OD, MPH
- Email: ascanz@uic.edu
- Phone: 312-996-3937
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Automated AI system to detect diabetic retinopathy in adults with diabetes
A AI-based software device is being tested to automatically detect diabetic retinopathy from retinal images in adults with diabetes.
-
N-acetylcysteine for diabetic retinopathy in adults with type 2 diabetes
This study tests whether taking N-acetylcysteine for three months can help people with type 2 diabetes who have mild to moderate diabetic retinopathy.
-
Early imaging changes with faricimab versus biosimilar ranibizumab for diabetic retinal disease
This trial will see if faricimab or a biosimilar ranibizumab causes different early OCT and OCTA imaging changes in adults with diabetic retinopathy or diabetic macular edema who need anti-VEGF injections.
-
Finding protein biomarkers for AMD, diabetic retinopathy, and retinal detachment
This project will test whether proteins found in blood and eye fluids can help diagnose or predict outcomes for adults with AMD, diabetic retinopathy, or retinal detachment.
-
Diabetic retinopathy prevalence and risk factors at a Da Nang hospital
We will find how common different stages of diabetic retinopathy are and which clinical or lab factors are linked to it among adults with diabetes treated at a Da Nang hospital.
-
AI-assisted retinal photo screening for adults with diabetes
This will test whether adding the VUNO Med®-Fundus AI tool to routine retinal photo screening helps adults with type 2 diabetes get more accurate referrals for diabetic retinopathy.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.